SNIPR Biome

About:

SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.

Website: https://www.sniprbiome.com

Top Investors: Bill & Melinda Gates Foundation, Wellington Partners, EQT Life Sciences, Lundbeckfonden Ventures, CARB-X

Description:

SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases. The company uses CRISPR technology that can subvert elements of the endogenous bacterial CRISPR machinery to eliminate hazardous bacteria in vivo, providing the health professionals with medicines that selectively target and kill bacteria with specific DNA sequences.

Total Funding Amount:

$62.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Copenhagen, Hovedstaden, Denmark

Founded Date:

2017-01-01

Contact Email:

contact(AT)sniprbiome.com

Founders:

Christian Groendahl, Jasper Clube, Morten O. A. Sommer

Number of Employees:

11-50

Last Funding Date:

2024-06-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai